These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7321189)

  • 1. [Clinical studies of dibekacin intravenous challenge on respiratory tract infections (author's transl)].
    Hayashi I; Okamoto H
    Jpn J Antibiot; 1981 Jul; 34(7):1098-105. PubMed ID: 7321189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum concentrations and clinical efficacy of dibekacin after intravenous drip infusion to patients with respiratory tract infections].
    Soejima R; Niki Y; Matsushima T; Tano Y
    Jpn J Antibiot; 1982 Dec; 35(12):2773-7. PubMed ID: 7182533
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical studies on dibekacin for infectious diseases following intramuscular and intravenous drip administration. Concentration in infected tissues and clinical responses (author's transl)].
    Nakamura T; Hashimoto I; Sawada Y; Mikami J; Bekki E; Kasai Y; Nakanishi M
    Jpn J Antibiot; 1981 Jun; 34(6):980-93. PubMed ID: 7289045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aerosol administration of dibekacin--the sputum concentration].
    Noguchi Y; Taguchi M; Takasugi M; Sakamoto T; Matsumoto K
    Jpn J Antibiot; 1983 Dec; 36(12):3405-11. PubMed ID: 6674552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of orbicin iv infusions in severe surgical infections. Serum level and clinical effect].
    Moorthi K; Ghobadi M; Schroer H
    Med Welt; 1980 Aug; 31(34):1209-10. PubMed ID: 6776380
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience with dibekacin (DKB) intravenous drip in the field of thoracic surgery (author's transl)].
    Nakabayashi M; Yamazaki N; Ito T
    Jpn J Antibiot; 1978 Nov; 31(11):693-6. PubMed ID: 731868
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study on administration method of dibekacin].
    Soejima R; Tano Y; Niki Y; Katoh O
    Jpn J Antibiot; 1982 Dec; 35(12):2768-72. PubMed ID: 7182532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fundamental and clinical studies on intravenous drip infusion of dibekacin in the pediatric field].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Sakaguchi Y; Kimura K
    Jpn J Antibiot; 1985 Aug; 38(8):2068-86. PubMed ID: 4079001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic studies on intravenous drip infusion of dibekacin in elderly subjects without apparent renal failure (author's transl)].
    Sawae Y; Okada K; Umemura K
    Jpn J Antibiot; 1982 Mar; 35(3):770-8. PubMed ID: 7097979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study on intravenous drip infusion of dibekacin once daily and twice daily in treatment of complicated urinary tract infections].
    Kishi H; Kaneco H; Tominaga T; Niijima T; Nishimura Y; Saito I; Ishii Y; Nito H; Yuge J; Asano M
    Hinyokika Kiyo; 1984 Jan; 30(1):103-20. PubMed ID: 6375317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies of dibekacin eye-drops. Intraocular penetration (author's transl)].
    Tomono N; Nakayoshi T; Fujita M; Kikai S; Oishi M
    Jpn J Antibiot; 1980 Jun; 33(6):685-9. PubMed ID: 7452907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fundamental studies of combination of antibiotics, especially on pharmacokinetics. III. Combination of ampicillin and dibekacin (author's transl)].
    Aratani H; Nakatsuka M
    Jpn J Antibiot; 1979 Jul; 32(7):711-9. PubMed ID: 490892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of highly resistant germs by dibekacin in patients with urinary tract infections (author's transl)].
    Peters HJ
    Med Klin; 1979 Jul; 74(27):1063-6. PubMed ID: 470791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Topical Dibekacin therapy of experimental Pseudomonas keratitis (author's transl)].
    Ohishi M; Nishizuka K; Motoyama M; Ogawa T
    Nippon Ganka Gakkai Zasshi; 1979; 83(10):2038-41. PubMed ID: 546191
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical studies on combination chemotherapy with fosfomycin and dibekacin in complicated urinary tract infection].
    Amano M; Okunobo T; Ueda H; Ura H; Sone A; Furukawa Y; Saito N; Tanaka H
    Hinyokika Kiyo; 1983 Aug; 29(8):947-52. PubMed ID: 6675445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dibekacin blood concentration following intravenous drip infusion (author's transl)].
    Kanazawa Y
    Jpn J Antibiot; 1979 May; 32(5):624-6. PubMed ID: 459090
    [No Abstract]   [Full Text] [Related]  

  • 17. [Concentration of dibekacin sulfate in bone (author's transl)].
    Kikuchi S; Hoshika I; Matsui T; Hasue M
    Jpn J Antibiot; 1982 Mar; 35(3):779-83. PubMed ID: 7097980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on intraocular injection of Dibekacin--toxic effects, clearance and experimental therapy of Pseudomonas endophthalmitis-(author's transl)].
    Oishi M; Nishizuka K; Motoyama M; Ogawa T
    Nippon Ganka Gakkai Zasshi; 1976 Oct; 80(10):1117-24. PubMed ID: 1034411
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of dibekacin in the treatment of external ocular infections, with special reference to the pseudomonas infection of the eye (author's transl)].
    Tokuda H; Amano R; Matsuda H; Nejime K; Tazawa Y; Shimada K; Uchida Y; Yamanishi R; Kotera K
    Nippon Ganka Gakkai Zasshi; 1981 Dec; 85(12):2126-37. PubMed ID: 7342734
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
    Saito M; Azuma K; Nishino T; Tanino T
    Jpn J Antibiot; 1983 Oct; 36(10):2833-43. PubMed ID: 6325746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.